NeuroMetrix (NURO +3.6%) announces that Omron Medical (Beijing) Ltd., its exclusive distributor of peripheral neuropathy test device DPNCheck in China, has inked a collaboration agreement with Yabao Pharmaceutical Co., Ltd. focused on promoting DPNCheck in north China, expanding the territory.
The specifics of the partnership agreement are not disclosed.
